Comment le zygote acquiert la totipotence à partir de deux cellules complètement différenciées, et comment les décisions du destin cellulaire sont faites plus tard dans le développement sont des questions biologiques essentielles. Les études menées au cours de la première partie de mon doctorat ont contribué à l'annotation de la composition de la chromatine embryonnaire en ce qui concerne les variantes des histones et des modifications post-traductionnelles. L'expression ectopique de H2A.Z après la fécondation réduit la progression du développement, ce qui suggère que l'absence de H2A.Z au début du développement pourrait être importante pour l'organisation de la chromatine embryonnaire nouvellement formée. Deuxièmement, j'ai étudié la dynamique des histones dans l'embryon de souris en développement. La reprogrammation épigénétique après la fécondation est accompagnée par une étonnante forte mobilité des histones dans le noyau. Ma thèse a contribué à la compréhension des événements dynamiques affectant la chromatine embryonnaire pendant le remodelage épigénétique après la fécondation. / How the zygote acquires totipotency from two differentiated cells, and how cell fate decisions are made later in development is a pivotal biological question. The studies conducted during the first part of my doctorate contributed to the annotation of embryonic chromatin composition with regards to histone variants and PTMs, and more specifically those correlated with active chromatin regions. The histone variant H2A.Z was shown to be present on embryonic chromatin in a stage-specific manner. Ectopic expression of H2A.Z after fertilization reduced developmental progression, suggesting that absence of H2A.Z at the onset of development might be important for the organization of the newly formed embryonic chromatin. Secondly, I investigated histone dynamics in the developing mouse embryo. Our work represents the first report on histone mobility during early mouse embryogenesis. My thesis contributed to the understanding of the dynamic events affecting embryonic chromatin during epigenetic remodeling after fertilization.

Le génome des cellules eucaryotes est empaqueté dans la chromatine, dont l’établissement et la maintenance nécessitent des processus d’assemblage et de remodelage. Ce travail de thèse a été consacré à la caractérisation de deux facteurs de la machinerie d’assemblage de la chromatine. Le premier facteur étudié dans ce travail était HIRIP3, un homologue mammifère de la levure H2A.Z chaperon Chz1. Nous voulions vérifier si HIRIP3 est une chaperon d'histone par elle-même. Pour commencer, nous avons décrit l'interaction de HIRIP3 avec les histones in vivo. Ensuite, nous avons étudié la spécificité structurale de cette interaction in vitro. Nous avons caractérisé HIRIP3 comme une nouvelle chaperon d'histone H2A qui utilise le motif CHZ pour sa fonction. La deuxième partie de ce travail a été axée sur le complexe de remodelage de la chromatine SRCAP. Nous avons cherché à décoder son réseau d'interaction et à décrire ses sous-complexes. Nous avons reconstitué le complexe de base YL1, SRCAP, TIP49A, TIP49B et H2A.Z / H2B en utilisant le système d'expression chez baculovirus. Notre protocole nous a permis de purifier un complexe de base adapté aux futures études structurelles par microscopie cryo-électronique. / The genome of eukaryotic cells is packaged into chromatin, which establishment and maintenance require mechanisms of assembly and remodelling. This thesis work was dedicated to the characterization of two factors of chromatin assembly machinery. The first factor studied in this work was HIRIP3, a mammalian homologue of yeast H2A.Z chaperone Chz1. We aimed to test whether HIRIP3 is a histone chaperone by itself. At first, we established HIRIP3 interaction with histones in vivo. After then, we studied the structural specificity of this interaction in vitro. We have characterized HIRIP3 as a novel H2A histone chaperone that utilizes the CHZ motif for its function. The second part of this work was focused on SRCAP chromatin remodelling complex. We aimed to decipher its interaction network and to describe its sub-complexes. We have reconstituted YL1, SRCAP, TIP49A, TIP49B and H2A.Z/H2B core complex using baculovirus expression system. Our protocol allowed us to purify core complex suitable for future structural studies by cryo-electron microscopy.

M.Sc. (Biochemistry) / Tuberculosis (TB) is an infectious disease that worldwide, is more prevalent in Africans compared to Caucasians. TB also affects males to a greater extent than females. Genetic associations between VDR sequence variants and TB is often inconsistent across different populations. Epigenetic and environmental factors, as well as ethnicity may confound associations found between VDR and TB...

Chromatin remodeling enzymes are instrumental for neural development as evidenced by their identification as disease genes underlying human disorders characterized by intellectual-disability. In this regard, the murine Snf2h and Snf2l genes show differential expression patterns during embryonic development, with a unique pattern in the brain where Snf2h is predominant in neural progenitors, while Snf2l expression peaks at the onset of differentiation. These observations led me to investigate the role of Snf2h and Snf2l in brain development by using conditionally targeted Snf2h and Snf2l mice. I selectively ablated Snf2h expression in cortical progenitors, cerebellar progenitors, or postmitotic Purkinje neurons of the cerebellum, while Snf2l was deleted in the germline. I found that Snf2h plays diverse roles in neural progenitor expansion and postmitotic gene expression control, while Snf2l is involved in the precise timing of neural differentiation onset. Gene expression studies revealed that Snf2h and Snf2l co-modulate the FoxG1 and En1 transcription factors during cortical and cerebellar neurogenesis, respectively, to precisely control the transition from a progenitor to a differentiated neuron. Moreover, Snf2h is essential for the postmitotic neural activation of the clustered protocadherin genes, and does so by functionally interacting with the matrix-attachment region protein Satb2. My neurobehavioral studies also provided insight into how Snf2h loss in cerebellar progenitors results in cerebellar ataxia, while Snf2h loss in cortical progenitors, or in postmitotic Purkinje neurons of the cerebellum, resulted in learning and memory deficits, and hyperactive-like behavior. Molecularly, Snf2h plays an important role in linker histone H1e dynamics and higher order chromatin packaging, as evidenced by loss of chromatin ultrastructure upon Snf2h deletion in progenitor and postmitotic neurons. I further demonstrated that Snf2h loss in a neuronal cell culture model results in reduced H1e deposition, and that overexpression of human SNF2H or SNF2L upon Snf2h knockdown rescues this biochemical dysfunction. My experiments suggest that Snf2h and Snf2l are regulatory nucleosome remodeling engines that co-modulate the gene expression programs necessary for proper brain development, maturation and function.

Au-delà de l'information génétique contenue dans la séquence de l'ADN des cellules, il existe une mémoire cellulaire, dite épigénétique comprenant l'ensemble des circuits génétiques avec rétroactions positives permettant d'amplifier ou de maintenir une réponse cellulaire dans le temps. Nous nous sommes intéressés, à travers deux exemples, aux boucles de rétrocontrôle positif comme élément de réponse à un signal, permettant de fixer, de manière à la fois dynamique et robuste, le comportement cellulaire. Dans un premier temps, nous avons identifié une boucle d'auto-amplification dans la production de vitellogénine chez la truite et permettant d'expliquer l' « effet mémoire de la vitellogénèse » (une seconde stimulation à l'œstradiol induit une plus forte production de vitellogénine et plus rapidement que lors de la première stimulation, alors même que le niveau de vitellogénine retombe à zéro entre les deux stimulations). Le modèle que nous proposons implique un récepteur tronqué à l'œstradiol possédant une activité basale même en l'absence de son ligand, permettant de maintenir la cellule dans un état d'aptitude à répondre sans pour autant produire de vitellogénine. Dans un deuxième temps, nous nous sommes intéressés à une des causes possibles provoquant la transition épithélio-mésenchymateuse (EMT), responsable des métastases dans les cancers. L'EMT témoigne d'un état plus agressif des cellules tumorales et s'accompagne notamment d'un changement du métabolisme des cellules cancéreuses, diminuant la part de la phosphorylation oxydative au profit de la glycolyse (effet Warburg). Cela entraîne une baisse d'efficacité de la production d'ATP, obligeant les cellules à prélever davantage de nutriments dans leur milieu. Cette observation a suscité le développement de thérapies basées sur la privation de glucose et qui, a priori, devraient nuire principalement aux cellules cancéreuses. Nous avons étudié les effets d'un faible contenu cellulaire en ATP sur la transformation cellulaire. Nous avons observé qu'un traitement par un analogue non métabolisable du glucose diminue drastiquement le contenu en ATP des cellules ayant passé l'EMT et induit des changements morphologiques et génétiques orientés vers le phénotype mésenchymateux. La protéine MKL1, cofacteur de transcription dont l'activité est régulée par la polymérisation de l'actine, pourrait être un relais génétique entre l'état métabolique cellulaire et le maintien de l'EMT. Ces résultats suggèrent de fortes connections entre l'EMT et le niveau énergétique des cellules, faisant d'une privation d'énergie une cause possible de l'aggravation du phénotype mésenchymateux et remettant en cause les bienfaits sur le long terme de thérapies visant à « affamer » les cellules tumorales. / Beyond the genetic information contained in the DNA sequence of cells, there is a cellular memory called epigenetic, including genetic circuits with positive feedback loops amplifying or maintaining cellular states in time. We studied through two examples, the positive feedback loops as part of response to a signal, able to set cell behavior, in a dynamic and robust way. As a first step, we identified a self-amplification loop in the production of trout vitellogenin explaining the "vitellogenesis memory effect" (a second estradiol stimulation induces higher and faster vitellogenin production than during the first stimulation, even though the vitellogenin level falls to zero between the two stimuli). The model we propose involves a truncated estradiol receptor, with a basal activity even in the absence of its ligand, which is able to maintain the cell in an estrogen-responsive state without producing vitellogenin. In a second step, we studied one of the possible causes leading to the epithelial-mesenchymal transition (EMT), involved in cancer metastasis. The EMT reflects a more aggressive state of tumor cells and is associated with a particular change in the metabolism of cancer cells, reducing the part of oxidative phosphorylation in favor of glycolysis (Warburg effect). This leads to a reduction in the efficiency of ATP production, forcing the cells to take more nutrients from their environment. This observation led to the development of treatments based on glucose deprivation which should mainly affect cancer cells. We studied the effects of a low cellular ATP content on cell transformation. We observed that a treatment with a non-metabolizable glucose analogue drastically reduces the ATP content of cells that had undergone EMT and induces morphological and genetic changes enforcing the mesenchymal phenotype. We identified the transcriptional coactivator MKL1, whose activity is regulated by actin polymerization, as a possible genetic link between the cellular metabolic state and maintenance of EMT. These results suggest strong connections between the EMT and the energy level of the cells, and raise serious questions about the benefits of the long-term therapy "starving" tumor cells, considering that energy deprivation could aggravate the mesenchymal cell phenotype.

En tant qu’organismes sessiles, les plantes doivent réagir rapidement et intensément, via des réponses défensives, pour repousser les pathogènes invasifs. Le système immunitaire des plantes peut être déclenché par des molécules élicitrices exogènes ou endogènes. Une autre classe d’éliciteurs, les éliciteurs synthétiques, contient également des composés promouvant une réponse défensive.Dans ce manuscrit, je décris la découverte et caractérisation d’une nouvelle famille de petits peptides endogènes potentiellement sécrétés(PROSCOOP), dont les membres incluent de petits peptides (SCOOP). Je démontre que les SCOOP sont impliqués dans les mécanismes de défense de la plante et le développement racinaire. Une variété de peptides SCOOP induit des réponses défensives de courtes et longues durées.De plus, des traitements avec le peptideSCOOP12 induisent une résistance à Pseudomonas syringae chez Arabidopsis.Dans la seconde partie de cette thèse, je démontre que le traitement des plantes avec un éliciteur synthétique peut mener à une mémoire transcriptionnelle à long terme, et que le challenge subséquent des plantes traitées par application d’un éliciteur exogène désactive cette mémoire transcriptionnelle. En conclusion, ma thèse présente (1) la diversité des fonctions que peuvent avoir ces éliciteurs et (2) l’impact sur les systèmes de défense de la plante et ses conséquences sur la mémoire et le développement de la plante. / As sessile organism, plants have to react quickly and strongly with defense responses to repel any invading pathogen. The plant immune system can be triggered by exogenous or endogenous elicitor molecules. Another class of elicitors are defense promoting compounds which are also known as synthetic elicitors. Here I describe the discovery and characterization of a novel family of potentially secreted small endogenous peptides (PROSCOOP) which members harbor small peptides (SCOOPs). I show that the SCOOP family is involved in plant defense and root development. Various SCOOP peptides induce short- and long-term defense responses. Moreover, treatments with the SCOOP12 peptide induce the resistance against Pseudomonas syringae in Arabidopsis. In the second part of this thesis, I show that treatments with a synthetic elicitor can lead to long-term transcriptional memory and that subsequent challenging of such plants with an exogenous elicitor reverted this transcriptional memory. In conclusion, my thesis shows (1) how diverse the function of these elicitors can be and (2) the impact the plant defense system and its triggers have on plant development and memory.

Shimamoto R, Amano N, Ichisaka T, Watanabe A, Yamanaka S, et al. (2014) Generation and Characterization of Induced Pluripotent Stem Cells from Aid-Deficient Mice. PLoS ONE 9(4): e94735. doi:10.1371/journal.pone.0094735 / 京都大学 / 0048 / 新制・課程博士 / 博士(医科学) / 甲第18515号 / 医科博第56号 / 新制||医科||4(附属図書館) / 31401 / 京都大学大学院医学研究科医科学専攻 / (主査)教授 斎藤 通紀, 教授 平家 俊男, 教授 山田 泰広 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Metastatic dissemination of breast cancer cells represents a significant clinical obstacle to curative therapy. While some progress has been made in the understanding of metastasis, the detailed molecular mechanisms that define the various stages of the process remain elusive. A major rate limiting step in metastasis is the loss of function of metastasis suppressor genes which block a cascade of crucial steps including the loss of adhesion of primary tumor cells, intravasation into the blood and lymphatics with subsequent extravasation at distant sites, and the formation of new colonies. Our examination of gene expression profiles from a breast cancer model system consisting of cell lines with the same genetic lineage representing the benign, carcinoma in situ and the metastatic stages led to the identification of a candidate metastasis suppressor gene, serum deprivation response (SDPR). We observed that stable SDPR over-expression in highly metastatic breast cancer model cell lines significantly suppressed metastatic nodule formation in NOD/SCID mice. Furthermore, meta-analysis of pre-existing gene expression data suggests that the loss of SDPR expression significantly correlated with relapse of breast cancer in patients who underwent therapy. We found that the mechanism of SDPR function involves activation of the p53 pathway and inhibition of ERK and NF-κB signaling pathways. SDPR increased the apoptotic population, hindered growth in 3D cell culture and impaired migration. Moreover, SDPR was suppressed by promoter DNA methylation in metastatic cell line models and its expression was restored by 5-aza-2'-deoxycytidine treatment. Together, our results reveal that SDPR is a novel metastasis suppressor gene with potential value as a target for future therapeutic applications.

BACKGROUND: It has long been accepted that the environment we experience can impact our well-being; throughout recorded history, the greatest prevalence and severity of disease has been experienced by marginalized and underserved populations. However, the translation of such nontangible influences into biological changes in our health has been elusive until the recent advent of epigenetic studies. Modifications outside of the genome play a critical role in regulating transcription as well as subsequent gene expression without altering DNA sequencing by controlling the accessibility of the DNA for interaction with key initiation proteins and enzymes. These modifications, which include DNA methylation, histone acetylation, and small noncoding microRNA regulation, have increasingly been found to have a fluid, adaptive response to experiences throughout life. Based on the literature supporting societal stressors negatively impacting neurologic outcome, as well as elucidating an association between epigenetic changes and adverse neurologic outcome, we hypothesize that alterations in CpG methylation sites associated with socioeconomic adversity will also be correlated with the incidence of Neurodevelopmental Disorders. METHODS: 889 of the 1,506 neonates initially recruited from 14 medical centers throughout the United States at their time of birth qualified to participate in this study. Placental samples were taken immediately following delivery and neonatal blood samples were taken within the first month of life. Children that survived were followed at 2 years old and 10 years old to evaluate for the presence of four possible Neurodevelopmental Disorders: cognitive impairment, Cerebral Palsy, Autism Spectrum Disorder, and epilepsy. Taking this data as well as demographic information into consideration, the entire cohort included in this study was first evaluated for aberrant methylation levels at 33 CpG sites previously associated with socioeconomic adversity to analyze the degree of significant correlation between altered methylation status and Neurodevelopmental Disorder prevalence. A secondary Epigenome-Wide Association Study was conducted for each of our 889 participants to pinpoint significant changes in CpG methylation in order to evaluate the relationship between altered methylation of particular genes and incidence of Neurodevelopmental Disorders. Taking the previous finding that cognitive impairment imposes a greater burden on both the individual and society than non-cognitive impairment into consideration, both analyses were categorized based on this measure of impairment severity: No Impairment, Non-Cognitive Impairment (diagnosed with Cerebral Palsy, Autism Spectrum Disorder, and/or epilepsy without cognitive deficit), and Cognitive Impairment (cognitive deficit with or without other neurodevelopmental disorders present). RESULTS: Primary analysis of the 33 CpG sites previously associated with socioeconomic adversity did not reveal any significant associations with Non-Cognitive or Cognitive Impairment. However, cg15519318 and cg10613063 (located in the PCCB gene) were marginally associated with Non-Cognitive Impairment while cg02765535 (located in the NTN4 gene) was marginally associated with Cognitive Impairment. Secondary analysis of the entire epigenome found 4 CpG sites significantly associated with Non-Cognitive Impairment (cg07322235, cg13592565, cg13723879, and cg24387818) as well as 4 CpG sites significantly associated with Cognitive Impairment (cg23081580, cg14134658, cg00762003, and cg08546514). DISCUSSION: We were not able to define a significant relationship between the CpG methylation sites related to socioeconomic adversity and adverse neurodevelopmental outcomes. This could stem from several causes, including insufficient power as well as limiting our evaluation of the extensive list of environmental influences to the four measures of societal stress focused on in this study (low educational attainment, single relationship status, public health insurance, and receiving supplemental nutrition assistance). Investigating the epigenome for differential methylation that was significantly associated with the incidence of Neurodevelopmental Disorders identified CpGs associated with several important genes, including genes coding for Neuregulin-3 (NRG3) and Premature Ovarian Failure Actin Binding Protein 1B (POF1B) region with Non-Cognitive Impairment as well as genes coding for Six-Transmembrane Epithelial Antigen of Prostate 2 Metalloreductase (STEAP2), Ly1 Antibody Reactive (LYAR), 1-Acylglycerol-3-Phosphate O-Acyltransferase 3 (AGPAT3), and Ninein-like protein (NINL) with Cognitive Impairment.